Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 165

1.

Correction: Income disparities in smoking cessation and the diffusion of smoke-free homes among U.S. smokers: Results from two longitudinal surveys.

Vijayaraghavan M, Benmarhnia T, Pierce JP, White MM, Kempster J, Shi Y, Trinidad DR, Messer K.

PLoS One. 2018 Nov 21;13(11):e0208153. doi: 10.1371/journal.pone.0208153. eCollection 2018.

2.

Discovery of a Novel Microtubule Targeting Agent as an Adjuvant for Cancer Immunotherapy.

Sato-Kaneko F, Wang X, Yao S, Hosoya T, Lao FS, Messer K, Pu M, Shukla NM, Cottam HB, Chan M, Carson DA, Corr M, Hayashi T.

Biomed Res Int. 2018 Oct 10;2018:8091283. doi: 10.1155/2018/8091283. eCollection 2018.

3.

Trends in lung cancer and cigarette smoking: California compared to the rest of the United States.

Pierce JP, Shi Y, McMenamin SB, Benmarhnia T, Trinidad DR, Strong DR, White MM, Kealey S, Hendrickson EM, Stone MD, Villasenor A, Kwong S, Zhang X, Messer K.

Cancer Prev Res (Phila). 2018 Oct 10. pii: canprevres.0341.2018. doi: 10.1158/1940-6207.CAPR-18-0341. [Epub ahead of print]

PMID:
30305281
4.

Effects of a Comprehensive Performance Improvement Strategy on Postoperative Adverse Events in Head and Neck Surgery.

Panuganti B, Qiu Y, Messing B, Lee G, Fakhry C, Blanco R, Ha P, Messer K, Califano JA.

Otolaryngol Head Neck Surg. 2018 Aug 28:194599818793887. doi: 10.1177/0194599818793887. [Epub ahead of print]

PMID:
30149772
5.

Income disparities in smoking cessation and the diffusion of smoke-free homes among U.S. smokers: Results from two longitudinal surveys.

Vijayaraghavan M, Benmarnhia T, Pierce JP, White MM, Kempster J, Shi Y, Trinidad DR, Messer K.

PLoS One. 2018 Jul 27;13(7):e0201467. doi: 10.1371/journal.pone.0201467. eCollection 2018. Erratum in: PLoS One. 2018 Nov 21;13(11):e0208153.

6.

Corrigendum: A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children's Oncology Group Study ANBL0931.

Ozkaynak MF, Gilman AL, London WB, Naranjo A, Diccianni MB, Tenney SC, Smith M, Messer KS, Seeger R, Reynolds CP, Smith LM, Shulkin BL, Parisi M, Maris JM, Park JR, Sondel PM, Yu AL.

Front Immunol. 2018 Jul 16;9:1641. doi: 10.3389/fimmu.2018.01641. eCollection 2018.

7.

A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children's Oncology Group Study ANBL0931.

Ozkaynak MF, Gilman AL, London WB, Naranjo A, Diccianni MB, Tenney SC, Smith M, Messer KS, Seeger R, Reynolds CP, Smith LM, Shulkin BL, Parisi M, Maris JM, Park JR, Sondel PM, Yu AL.

Front Immunol. 2018 Jun 18;9:1355. doi: 10.3389/fimmu.2018.01355. eCollection 2018. Erratum in: Front Immunol. 2018 Jul 16;9:1641.

8.

A Framework for Leveraging "Big Data" to Advance Epidemiology and Improve Quality: Design of the VA Colonoscopy Collaborative.

Gupta S, Liu L, Patterson OV, Earles A, Bustamante R, Gawron AJ, Thompson WK, Scuba W, Denhalter D, Martinez ME, Messer K, Fisher DA, Saini SD, DuVall SL, Chapman WW, Whooley MA, Kaltenbach T.

EGEMS (Wash DC). 2018 Apr 13;6(1):4. doi: 10.5334/egems.198.

9.

Phase I Trial: Cirmtuzumab Inhibits ROR1 Signaling and Stemness Signatures in Patients with Chronic Lymphocytic Leukemia.

Choi MY, Widhopf GF 2nd, Ghia EM, Kidwell RL, Hasan MK, Yu J, Rassenti LZ, Chen L, Chen Y, Pittman E, Pu M, Messer K, Prussak CE, Castro JE, Jamieson C, Kipps TJ.

Cell Stem Cell. 2018 Jun 1;22(6):951-959.e3. doi: 10.1016/j.stem.2018.05.018.

PMID:
29859176
10.

Identification of Compounds That Prolong Type I Interferon Signaling as Potential Vaccine Adjuvants.

Shukla NM, Arimoto KI, Yao S, Fan JB, Zhang Y, Sato-Kaneko F, Lao FS, Hosoya T, Messer K, Pu M, Cottam HB, Carson DA, Hayashi T, Zhang DE, Corr M.

SLAS Discov. 2018 Oct;23(9):960-973. doi: 10.1177/2472555218774308. Epub 2018 May 11.

PMID:
29751735
11.

Paternally inherited cis-regulatory structural variants are associated with autism.

Brandler WM, Antaki D, Gujral M, Kleiber ML, Whitney J, Maile MS, Hong O, Chapman TR, Tan S, Tandon P, Pang T, Tang SC, Vaux KK, Yang Y, Harrington E, Juul S, Turner DJ, Thiruvahindrapuram B, Kaur G, Wang Z, Kingsmore SF, Gleeson JG, Bisson D, Kakaradov B, Telenti A, Venter JC, Corominas R, Toma C, Cormand B, Rueda I, Guijarro S, Messer KS, Nievergelt CM, Arranz MJ, Courchesne E, Pierce K, Muotri AR, Iakoucheva LM, Hervas A, Scherer SW, Corsello C, Sebat J.

Science. 2018 Apr 20;360(6386):327-331. doi: 10.1126/science.aan2261.

12.

Positive Surgical Margins in the 10 Most Common Solid Cancers.

Orosco RK, Tapia VJ, Califano JA, Clary B, Cohen EEW, Kane C, Lippman SM, Messer K, Molinolo A, Murphy JD, Pang J, Sacco A, Tringale KR, Wallace A, Nguyen QT.

Sci Rep. 2018 Apr 9;8(1):5686. doi: 10.1038/s41598-018-23403-5.

13.

Association Between Receptivity to Tobacco Advertising and Progression to Tobacco Use in Youth and Young Adults in the PATH Study.

Pierce JP, Sargent JD, Portnoy DB, White M, Noble M, Kealey S, Borek N, Carusi C, Choi K, Green VR, Kaufman AR, Leas E, Lewis MJ, Margolis KA, Messer K, Shi Y, Silveira ML, Snyder K, Stanton CA, Tanski SE, Bansal-Travers M, Trinidad D, Hyland A.

JAMA Pediatr. 2018 May 1;172(5):444-451. doi: 10.1001/jamapediatrics.2017.5756.

14.

A Phase I/II Trial of the Combination of Azacitidine and Gemtuzumab Ozogamicin for Treatment of Relapsed Acute Myeloid Leukemia.

Medeiros BC, Tanaka TN, Balaian L, Bashey A, Guzdar A, Li H, Messer K, Ball ED.

Clin Lymphoma Myeloma Leuk. 2018 May;18(5):346-352.e5. doi: 10.1016/j.clml.2018.02.017. Epub 2018 Mar 2.

PMID:
29572158
15.

Integrated Analysis of Exosomal Protein Biomarkers on Alternating Current Electrokinetic Chips Enables Rapid Detection of Pancreatic Cancer in Patient Blood.

Lewis JM, Vyas AD, Qiu Y, Messer KS, White R, Heller MJ.

ACS Nano. 2018 Apr 24;12(4):3311-3320. doi: 10.1021/acsnano.7b08199. Epub 2018 Mar 28.

PMID:
29570265
16.

Fluorine-19 nuclear magnetic resonance of chimeric antigen receptor T cell biodistribution in murine cancer model.

Chapelin F, Gao S, Okada H, Weber TG, Messer K, Ahrens ET.

Sci Rep. 2017 Dec 18;7(1):17748. doi: 10.1038/s41598-017-17669-4.

17.

Tobacco control in California compared with the rest of the USA: trends in adult per capita cigarette consumption.

Pierce JP, Shi Y, Hendrickson EM, White MM, Noble ML, Kealey S, Strong DR, Trinidad DR, Hartman AM, Messer K.

Tob Control. 2018 Oct;27(e2):e112-e117. doi: 10.1136/tobaccocontrol-2017-053895. Epub 2017 Nov 27.

PMID:
29180534
18.

A cerebrospinal fluid microRNA signature as biomarker for glioblastoma.

Akers JC, Hua W, Li H, Ramakrishnan V, Yang Z, Quan K, Zhu W, Li J, Figueroa J, Hirshman BR, Miller B, Piccioni D, Ringel F, Komotar R, Messer K, Galasko DR, Hochberg F, Mao Y, Carter BS, Chen CC.

Oncotarget. 2017 Jun 1;8(40):68769-68779. doi: 10.18632/oncotarget.18332. eCollection 2017 Sep 15.

19.

Combination immunotherapy with TLR agonists and checkpoint inhibitors suppresses head and neck cancer.

Sato-Kaneko F, Yao S, Ahmadi A, Zhang SS, Hosoya T, Kaneda MM, Varner JA, Pu M, Messer KS, Guiducci C, Coffman RL, Kitaura K, Matsutani T, Suzuki R, Carson DA, Hayashi T, Cohen EE.

JCI Insight. 2017 Sep 21;2(18). pii: 93397. doi: 10.1172/jci.insight.93397. [Epub ahead of print]

20.

Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice.

Goff PH, Hayashi T, He W, Yao S, Cottam HB, Tan GS, Crain B, Krammer F, Messer K, Pu M, Carson DA, Palese P, Corr M.

J Virol. 2017 Sep 12;91(19). pii: e01050-17. doi: 10.1128/JVI.01050-17. Print 2017 Oct 1.

21.

Analysis of extracellular RNA in cerebrospinal fluid.

Saugstad JA, Lusardi TA, Van Keuren-Jensen KR, Phillips JI, Lind B, Harrington CA, McFarland TJ, Courtright AL, Reiman RA, Yeri AS, Kalani MYS, Adelson PD, Arango J, Nolan JP, Duggan E, Messer K, Akers JC, Galasko DR, Quinn JF, Carter BS, Hochberg FH.

J Extracell Vesicles. 2017 May 24;6(1):1317577. doi: 10.1080/20013078.2017.1317577. eCollection 2017.

22.

Identification of Biologically Active Pyrimido[5,4-b]indoles That Prolong NF-κB Activation without Intrinsic Activity.

Chan M, Ahmadi A, Yao S, Sato-Kaneko F, Messer K, Pu M, Nguyen B, Hayashi T, Corr M, Carson DA, Cottam HB, Shukla NM.

ACS Comb Sci. 2017 Aug 14;19(8):533-543. doi: 10.1021/acscombsci.7b00080. Epub 2017 Jul 13.

23.

Genetic evidence that β-arrestins are dispensable for the initiation of β2-adrenergic receptor signaling to ERK.

O'Hayre M, Eichel K, Avino S, Zhao X, Steffen DJ, Feng X, Kawakami K, Aoki J, Messer K, Sunahara R, Inoue A, von Zastrow M, Gutkind JS.

Sci Signal. 2017 Jun 20;10(484). pii: eaal3395. doi: 10.1126/scisignal.aal3395.

24.

Receptivity to Tobacco Advertising and Susceptibility to Tobacco Products.

Pierce JP, Sargent JD, White MM, Borek N, Portnoy DB, Green VR, Kaufman AR, Stanton CA, Bansal-Travers M, Strong DR, Pearson JL, Coleman BN, Leas E, Noble ML, Trinidad DR, Moran MB, Carusi C, Hyland A, Messer K.

Pediatrics. 2017 Jun;139(6). pii: e20163353. doi: 10.1542/peds.2016-3353.

25.

Susceptibility to tobacco product use among youth in wave 1 of the population Assessment of tobacco and health (PATH) study.

Trinidad DR, Pierce JP, Sargent JD, White MM, Strong DR, Portnoy DB, Green VR, Stanton CA, Choi K, Bansal-Travers M, Shi Y, Pearson JL, Kaufman AR, Borek N, Coleman BN, Hyland A, Carusi C, Kealey S, Leas E, Noble ML, Messer K.

Prev Med. 2017 Aug;101:8-14. doi: 10.1016/j.ypmed.2017.05.010. Epub 2017 May 17.

26.

Detection of wild-type EGFR amplification and EGFRvIII mutation in CSF-derived extracellular vesicles of glioblastoma patients.

Figueroa JM, Skog J, Akers J, Li H, Komotar R, Jensen R, Ringel F, Yang I, Kalkanis S, Thompson R, LoGuidice L, Berghoff E, Parsa A, Liau L, Curry W, Cahill D, Bettegowda C, Lang FF, Chiocca EA, Henson J, Kim R, Breakefield X, Chen C, Messer K, Hochberg F, Carter BS.

Neuro Oncol. 2017 Oct 19;19(11):1494-1502. doi: 10.1093/neuonc/nox085.

27.

Pre-adolescent Receptivity to Tobacco Marketing and Its Relationship to Acquiring Friends Who Smoke and Cigarette Smoking Initiation.

Strong DR, Messer K, Hartman SJ, Nodora J, Vera L, White MM, Leas E, Pharris-Ciurej N, Borek N, Pierce JP.

Ann Behav Med. 2017 Oct;51(5):730-740. doi: 10.1007/s12160-017-9896-y.

28.

Corrigendum: PI3Kγ is a molecular switch that controls immune suppression.

Kaneda MM, Messer KS, Ralainirina N, Li H, Leem CJ, Gorjestani S, Woo G, Nguyen AV, Figueiredo CC, Foubert P, Schmid MC, Pink M, Winkler DG, Rausch M, Palombella VJ, Kutok J, McGovern K, Frazer KA, Wu X, Karin M, Sasik R, Cohen EE, Varner JA.

Nature. 2017 Feb 2;542(7639):124. doi: 10.1038/nature21026. Epub 2016 Dec 14. No abstract available.

PMID:
27974794
29.

PI3Kγ is a molecular switch that controls immune suppression.

Kaneda MM, Messer KS, Ralainirina N, Li H, Leem CJ, Gorjestani S, Woo G, Nguyen AV, Figueiredo CC, Foubert P, Schmid MC, Pink M, Winkler DG, Rausch M, Palombella VJ, Kutok J, McGovern K, Frazer KA, Wu X, Karin M, Sasik R, Cohen EE, Varner JA.

Nature. 2016 Nov 17;539(7629):437-442. doi: 10.1038/nature19834. Epub 2016 Sep 19. Erratum in: Nature. 2017 Feb 2;542(7639):124.

30.

E-cigarette use and smoking reduction or cessation in the 2010/2011 TUS-CPS longitudinal cohort.

Shi Y, Pierce JP, White M, Vijayaraghavan M, Compton W, Conway K, Hartman AM, Messer K.

BMC Public Health. 2016 Oct 21;16(1):1105.

31.

A prognostic model for advanced colorectal neoplasia recurrence.

Liu L, Messer K, Baron JA, Lieberman DA, Jacobs ET, Cross AJ, Murphy G, Martinez ME, Gupta S.

Cancer Causes Control. 2016 Oct;27(10):1175-85. doi: 10.1007/s10552-016-0795-5. Epub 2016 Aug 12.

32.

Design and methods of the Population Assessment of Tobacco and Health (PATH) Study.

Hyland A, Ambrose BK, Conway KP, Borek N, Lambert E, Carusi C, Taylor K, Crosse S, Fong GT, Cummings KM, Abrams D, Pierce JP, Sargent J, Messer K, Bansal-Travers M, Niaura R, Vallone D, Hammond D, Hilmi N, Kwan J, Piesse A, Kalton G, Lohr S, Pharris-Ciurej N, Castleman V, Green VR, Tessman G, Kaufman A, Lawrence C, van Bemmel DM, Kimmel HL, Blount B, Yang L, O'Brien B, Tworek C, Alberding D, Hull LC, Cheng YC, Maklan D, Backinger CL, Compton WM.

Tob Control. 2017 Jul;26(4):371-378. doi: 10.1136/tobaccocontrol-2016-052934. Epub 2016 Aug 8.

33.

PI-3K Inhibitors Preferentially Target CD15+ Cancer Stem Cell Population in SHH Driven Medulloblastoma.

Singh AR, Joshi S, Zulcic M, Alcaraz M, Garlich JR, Morales GA, Cho YJ, Bao L, Levy ML, Newbury R, Malicki D, Messer K, Crawford J, Durden DL.

PLoS One. 2016 Mar 3;11(3):e0150836. doi: 10.1371/journal.pone.0150836. eCollection 2016.

34.

Prognostic Impact of Modulators of G proteins in Circulating Tumor Cells from Patients with Metastatic Colorectal Cancer.

Barbazan J, Dunkel Y, Li H, Nitsche U, Janssen KP, Messer K, Ghosh P.

Sci Rep. 2016 Feb 26;6:22112. doi: 10.1038/srep22112.

35.

A Novel Tool for Predicting Major Complications After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.

Baumgartner JM, Kwong TG, Ma GL, Messer K, Kelly KJ, Lowy AM.

Ann Surg Oncol. 2016 May;23(5):1609-17. doi: 10.1245/s10434-015-5012-3. Epub 2015 Dec 17.

36.

Mutational Profiling Can Establish Clonal or Independent Origin in Synchronous Bilateral Breast and Other Tumors.

Bao L, Messer K, Schwab R, Harismendy O, Pu M, Crain B, Yost S, Frazer KA, Rana B, Hasteh F, Wallace A, Parker BA.

PLoS One. 2015 Nov 10;10(11):e0142487. doi: 10.1371/journal.pone.0142487. eCollection 2015.

37.

Multipotent luminal mammary cancer stem cells model tumor heterogeneity.

Bao L, Cardiff RD, Steinbach P, Messer KS, Ellies LG.

Breast Cancer Res. 2015 Oct 14;17(1):137. doi: 10.1186/s13058-015-0615-y.

38.

A window-of-opportunity biomarker study of etodolac in resectable breast cancer.

Schwab RB, Kato S, Crain B, Pu M, Messer K, Weidner N, Blair SL, Wallace AM, Carson DA, Parker BA.

Cancer Med. 2015 Oct;4(10):1583-8. doi: 10.1002/cam4.512. Epub 2015 Aug 15.

39.

Cigarette smoking cessation attempts among current US smokers who also use smokeless tobacco.

Messer K, Vijayaraghavan M, White MM, Shi Y, Chang C, Conway KP, Hartman A, Schroeder MJ, Compton WM, Pierce JP.

Addict Behav. 2015 Dec;51:113-9. doi: 10.1016/j.addbeh.2015.06.045. Epub 2015 Jul 4.

40.

Measurement of multiple nicotine dependence domains among cigarette, non-cigarette and poly-tobacco users: Insights from item response theory.

Strong DR, Messer K, Hartman SJ, Conway KP, Hoffman AC, Pharris-Ciurej N, White M, Green VR, Compton WM, Pierce J.

Drug Alcohol Depend. 2015 Jul 1;152:185-93. doi: 10.1016/j.drugalcdep.2015.03.040. Epub 2015 Apr 27.

41.

GLI2 inhibition abrogates human leukemia stem cell dormancy.

Sadarangani A, Pineda G, Lennon KM, Chun HJ, Shih A, Schairer AE, Court AC, Goff DJ, Prashad SL, Geron I, Wall R, McPherson JD, Moore RA, Pu M, Bao L, Jackson-Fisher A, Munchhof M, VanArsdale T, Reya T, Morris SR, Minden MD, Messer K, Mikkola HK, Marra MA, Hudson TJ, Jamieson CH.

J Transl Med. 2015 Mar 21;13:98. doi: 10.1186/s12967-015-0453-9.

42.

Genetic and epigenetic profiling of CLL disease progression reveals limited somatic evolution and suggests a relationship to memory-cell development.

Smith EN, Ghia EM, DeBoever CM, Rassenti LZ, Jepsen K, Yoon KA, Matsui H, Rozenzhak S, Alakus H, Shepard PJ, Dai Y, Khosroheidari M, Bina M, Gunderson KL, Messer K, Muthuswamy L, Hudson TJ, Harismendy O, Barrett CL, Jamieson CH, Carson DA, Kipps TJ, Frazer KA.

Blood Cancer J. 2015 Apr 10;5:e303. doi: 10.1038/bcj.2015.14.

43.

Psychiatric readmissions in a community-based sample of patients with mental disorders.

Vijayaraghavan M, Messer K, Xu Z, Sarkin A, Gilmer TP.

Psychiatr Serv. 2015 May 1;66(5):551-4. doi: 10.1176/appi.ps.201400092. Epub 2015 Mar 31.

44.

Augmentation of autologous T cell reactivity with acute myeloid leukemia (AML) blasts by Toll-like receptor (TLR) agonists.

Zhong R, Li H, Messer K, Lane TA, Zhou J, Ball ED.

Cancer Immunol Immunother. 2015 Jun;64(6):737-44. doi: 10.1007/s00262-015-1680-x. Epub 2015 Mar 21.

45.

Fluorescently labeled peptide increases identification of degenerated facial nerve branches during surgery and improves functional outcome.

Hussain T, Mastrodimos MB, Raju SC, Glasgow HL, Whitney M, Friedman B, Moore JD, Kleinfeld D, Steinbach P, Messer K, Pu M, Tsien RY, Nguyen QT.

PLoS One. 2015 Mar 9;10(3):e0119600. doi: 10.1371/journal.pone.0119600. eCollection 2015.

46.

Optical antenna enhanced spontaneous emission.

Eggleston MS, Messer K, Zhang L, Yablonovitch E, Wu MC.

Proc Natl Acad Sci U S A. 2015 Feb 10;112(6):1704-9. doi: 10.1073/pnas.1423294112. Epub 2015 Jan 26.

47.

Synthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responses.

Goff PH, Hayashi T, Martínez-Gil L, Corr M, Crain B, Yao S, Cottam HB, Chan M, Ramos I, Eggink D, Heshmati M, Krammer F, Messer K, Pu M, Fernandez-Sesma A, Palese P, Carson DA.

J Virol. 2015 Mar;89(6):3221-35. doi: 10.1128/JVI.03337-14. Epub 2015 Jan 7.

48.

Surgical molecular navigation with ratiometric activatable cell penetrating peptide for intraoperative identification and resection of small salivary gland cancers.

Hussain T, Savariar EN, Diaz-Perez JA, Messer K, Pu M, Tsien RY, Nguyen QT.

Head Neck. 2016 May;38(5):715-23. doi: 10.1002/hed.23946. Epub 2015 Jun 22.

49.

Predictive Validity of the Expanded Susceptibility to Smoke Index.

Strong DR, Hartman SJ, Nodora J, Messer K, James L, White M, Portnoy DB, Choiniere CJ, Vullo GC, Pierce J.

Nicotine Tob Res. 2015 Jul;17(7):862-9. doi: 10.1093/ntr/ntu254. Epub 2014 Dec 6.

50.

Circulating extracellular vesicles with specific proteome and liver microRNAs are potential biomarkers for liver injury in experimental fatty liver disease.

Povero D, Eguchi A, Li H, Johnson CD, Papouchado BG, Wree A, Messer K, Feldstein AE.

PLoS One. 2014 Dec 3;9(12):e113651. doi: 10.1371/journal.pone.0113651. eCollection 2014.

Supplemental Content

Loading ...
Support Center